62 research outputs found

    Conservation laws and scattering for de Sitter classical particles

    Full text link
    Starting from an intrinsic geometric characterization of de Sitter timelike and lightlike geodesics we give a new description of the conserved quantities associated with classical free particles on the de Sitter manifold. These quantities allow for a natural discussion of classical pointlike scattering and decay processes. We also provide an intrinsic definition of energy of a classical de Sitter particle and discuss its different expressions in various local coordinate systems and their relations with earlier definitions found in the literature.Comment: 25 pages, 1 figur

    Alpha-states in de Sitter space

    Get PDF
    Field theory in de Sitter space admits a one-parameter family of vacua determined by a superselection parameter alpha. Of these vacua, the Euclidean vacuum uniquely extrapolates to the vacuum of flat Minkowski space. States which resemble the alpha-vacua can be constructed as excitations above the Euclidean vacuum. Such states have modes alpha(k) which decay faster that k^{(1-d)/2}. Fields in such states exhibit non-local correlations when examined from the perspective of fields in the Euclidean vacuum. The dynamics of such entangled states are fully consistent. If an alpha-state with properties that interpolate between an alpha-vacuum and the Euclidean vacuum were the initial condition for inflation, a signature for this may be found in a momentum dependent correction to the inflationary power spectrum. The functional formalism, which provides the tool for examining physics in an alpha-state, extends to fields of other spin. In particular, the extension to spin-2 may proffer a new class of infrared modifications to gravitational interactions. The implications of superselection sectors for the landscape of string vacua are briefly discussed.Comment: 28 pages, LaTe

    Equations of Motion of Spinning Relativistic Particle in Electromagnetic and Gravitational Fields

    Full text link
    We consider the motion of a spinning relativistic particle in external electromagnetic and gravitational fields, to first order in the external field, but to an arbitrary order in spin. The noncovariant spin formalism is crucial for the correct description of the influence of the spin on the particle trajectory. We show that the true coordinate of a relativistic spinning particle is its naive, common coordinate \r. Concrete calculations are performed up to second order in spin included. A simple derivation is presented for the gravitational spin-orbit and spin-spin interactions of a relativistic particle. We discuss the gravimagnetic moment (GM), a specific spin effect in general relativity. It is shown that for the Kerr black hole the gravimagnetic ratio, i.e., the coefficient at the GM, equals unity (just as for the charged Kerr hole the gyromagnetic ratio equals two). The equations of motion obtained for relativistic spinning particle in external gravitational field differ essentially from the Papapetrou equations.Comment: 32 pages, latex, Plenary talk at the Fairbank Meeting on the Lense--Thirring Effect, Rome-Pescara, 29/6-4/7 199

    Equations of Motion of Spinning Relativistic Particle in External Fields

    Get PDF
    We consider the motion of a spinning relativistic particle in external electromagnetic and gravitational fields, to first order in the external field, but to an arbitrary order in spin. The correct account for the spin influence on the particle trajectory is obtained with the noncovariant description of spin. Concrete calculations are performed up to second order in spin included. A simple derivation is presented for the gravitational spin-orbit and spin-spin interactions of a relativistic particle. We discuss the gravimagnetic moment (GM), a specific spin effect in general relativity. It is demonstrated that for the Kerr black hole the gravimagnetic ratio, i.e., the coefficient at the GM, equals to unity (as well as for the charged Kerr hole the gyromagnetic ratio equals to two). The equations of motion obtained for relativistic spinning particle in external gravitational field differ essentially from the Papapetrou equations.Comment: 22 pages, latex, no figure

    On the problem of interactions in quantum theory

    Full text link
    The structure of representations describing systems of free particles in the theory with the invariance group SO(1,4) is investigated. The property of the particles to be free means as usual that the representation describing a many-particle system is the tensor product of the corresponding single-particle representations (i.e. no interaction is introduced). It is shown that the mass operator contains only continuous spectrum in the interval (,)(-\infty,\infty) and such representations are unitarily equivalent to ones describing interactions (gravitational, electromagnetic etc.). This means that there are no bound states in the theory and the Hilbert space of the many-particle system contains a subspace of states with the following property: the action of free representation operators on these states is manifested in the form of different interactions. Possible consequences of the results are discussed.Comment: 35 pages, Late

    A measure on the set of compact Friedmann-Lemaitre-Robertson-Walker models

    Full text link
    Compact, flat Friedmann-Lemaitre-Robertson-Walker (FLRW) models have recently regained interest as a good fit to the observed cosmic microwave background temperature fluctuations. However, it is generally thought that a globally, exactly-flat FLRW model is theoretically improbable. Here, in order to obtain a probability space on the set F of compact, comoving, 3-spatial sections of FLRW models, a physically motivated hypothesis is proposed, using the density parameter Omega as a derived rather than fundamental parameter. We assume that the processes that select the 3-manifold also select a global mass-energy and a Hubble parameter. The inferred range in Omega consists of a single real value for any 3-manifold. Thus, the obvious measure over F is the discrete measure. Hence, if the global mass-energy and Hubble parameter are a function of 3-manifold choice among compact FLRW models, then probability spaces parametrised by Omega do not, in general, give a zero probability of a flat model. Alternatively, parametrisation by the injectivity radius r_inj ("size") suggests the Lebesgue measure. In this case, the probability space over the injectivity radius implies that flat models occur almost surely (a.s.), in the sense of probability theory, and non-flat models a.s. do not occur.Comment: 19 pages, 4 figures; v2: minor language improvements; v3: generalisation: m, H functions of

    A review of elliptical and disc galaxy structure, and modern scaling laws

    Full text link
    A century ago, in 1911 and 1913, Plummer and then Reynolds introduced their models to describe the radial distribution of stars in `nebulae'. This article reviews the progress since then, providing both an historical perspective and a contemporary review of the stellar structure of bulges, discs and elliptical galaxies. The quantification of galaxy nuclei, such as central mass deficits and excess nuclear light, plus the structure of dark matter halos and cD galaxy envelopes, are discussed. Issues pertaining to spiral galaxies including dust, bulge-to-disc ratios, bulgeless galaxies, bars and the identification of pseudobulges are also reviewed. An array of modern scaling relations involving sizes, luminosities, surface brightnesses and stellar concentrations are presented, many of which are shown to be curved. These 'redshift zero' relations not only quantify the behavior and nature of galaxies in the Universe today, but are the modern benchmark for evolutionary studies of galaxies, whether based on observations, N-body-simulations or semi-analytical modelling. For example, it is shown that some of the recently discovered compact elliptical galaxies at 1.5 < z < 2.5 may be the bulges of modern disc galaxies.Comment: Condensed version (due to Contract) of an invited review article to appear in "Planets, Stars and Stellar Systems"(www.springer.com/astronomy/book/978-90-481-8818-5). 500+ references incl. many somewhat forgotten, pioneer papers. Original submission to Springer: 07-June-201

    Exploring new physics frontiers through numerical relativity

    Get PDF
    The demand to obtain answers to highly complex problems within strong-field gravity has been met with significant progress in the numerical solution of Einstein's equations - along with some spectacular results - in various setups. We review techniques for solving Einstein's equations in generic spacetimes, focusing on fully nonlinear evolutions but also on how to benchmark those results with perturbative approaches. The results address problems in high-energy physics, holography, mathematical physics, fundamental physics, astrophysics and cosmology

    Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

    Get PDF
    Background: The EMPA KIDNEY trial showed that empagliflozin reduced the risk of the primary composite outcome of kidney disease progression or cardiovascular death in patients with chronic kidney disease mainly through slowing progression. We aimed to assess how effects of empagliflozin might differ by primary kidney disease across its broad population. Methods: EMPA-KIDNEY, a randomised, controlled, phase 3 trial, was conducted at 241 centres in eight countries (Canada, China, Germany, Italy, Japan, Malaysia, the UK, and the USA). Patients were eligible if their estimated glomerular filtration rate (eGFR) was 20 to less than 45 mL/min per 1·73 m2, or 45 to less than 90 mL/min per 1·73 m2 with a urinary albumin-to-creatinine ratio (uACR) of 200 mg/g or higher at screening. They were randomly assigned (1:1) to 10 mg oral empagliflozin once daily or matching placebo. Effects on kidney disease progression (defined as a sustained ≥40% eGFR decline from randomisation, end-stage kidney disease, a sustained eGFR below 10 mL/min per 1·73 m2, or death from kidney failure) were assessed using prespecified Cox models, and eGFR slope analyses used shared parameter models. Subgroup comparisons were performed by including relevant interaction terms in models. EMPA-KIDNEY is registered with ClinicalTrials.gov, NCT03594110. Findings: Between May 15, 2019, and April 16, 2021, 6609 participants were randomly assigned and followed up for a median of 2·0 years (IQR 1·5–2·4). Prespecified subgroupings by primary kidney disease included 2057 (31·1%) participants with diabetic kidney disease, 1669 (25·3%) with glomerular disease, 1445 (21·9%) with hypertensive or renovascular disease, and 1438 (21·8%) with other or unknown causes. Kidney disease progression occurred in 384 (11·6%) of 3304 patients in the empagliflozin group and 504 (15·2%) of 3305 patients in the placebo group (hazard ratio 0·71 [95% CI 0·62–0·81]), with no evidence that the relative effect size varied significantly by primary kidney disease (pheterogeneity=0·62). The between-group difference in chronic eGFR slopes (ie, from 2 months to final follow-up) was 1·37 mL/min per 1·73 m2 per year (95% CI 1·16–1·59), representing a 50% (42–58) reduction in the rate of chronic eGFR decline. This relative effect of empagliflozin on chronic eGFR slope was similar in analyses by different primary kidney diseases, including in explorations by type of glomerular disease and diabetes (p values for heterogeneity all &gt;0·1). Interpretation: In a broad range of patients with chronic kidney disease at risk of progression, including a wide range of non-diabetic causes of chronic kidney disease, empagliflozin reduced risk of kidney disease progression. Relative effect sizes were broadly similar irrespective of the cause of primary kidney disease, suggesting that SGLT2 inhibitors should be part of a standard of care to minimise risk of kidney failure in chronic kidney disease. Funding: Boehringer Ingelheim, Eli Lilly, and UK Medical Research Council

    EPMA position paper in cancer: current overview and future perspectives

    Get PDF
    corecore